James Thrasher

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology · 2019 · 295 citations

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

Diabetes Technology & Therapeutics · 2022 · 186 citations